本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

19.91
-0.1600-0.80%
成交量:67.83萬
成交額:1,338.79萬
市值:25.45億
市盈率:115.48
高:20.12
開:20.00
低:19.34
收:20.07
52周最高:30.48
52周最低:16.10
股本:1.28億
流通股本:7,811.99萬
量比:0.37
換手率:0.87%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
淨資產收益率:7.48%
總資產收益率:3.53%
市淨率:6.88
市盈率(LYR):115.48

資料載入中...

2023/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/29

重要事件披露

Form 8-K - Current report
2023/08/22

重要事件披露

Form 8-K - Current report
2023/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/31

重要事件披露

Form 8-K - Current report
2023/07/19

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/17

重要事件披露

Form 8-K - Current report
2023/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities